[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday

The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.

As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.

This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.

Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.